TTA’s summer startup #3: Samsung’s skin sensor, UK GPDPR delayed till Sept, practice models consolidate, UK company news, Theranos’ jury antics, Holmes as meme, more!

 

 

Weekly Alert

A win for UK GPs–and patient privacy–with GPDPR postponed till September. Samsung revives skin sensors, concierge care meets Medicare Advantage, transplant health consolidates, plus UK companies revive. The (expected) slugfest over jury screening for Theranos, with the surprise of Elizabeth Holmes becoming a merchandisable meme. And Chubb weighs in on the challenges for digital health in the UK analogue vs. digital telecom change.

Samsung stretches into electronic skin sensors with OLED display for heart rate (A big step forward in ‘all in one’ sensors and displays)
NHS Digital GPDPR medical database data extraction start postponed from 1 July to 1 September (Forced by revolting GPs and legal action including an MP)
News and deal roundup: OneMedical’s $2.1 bn for Iora, CareDx buys Transplant Hero, Mount Sinai’s Elementa Labs; UK news–NHSX/Babylon, Doro-Everon, Tunstall (May be cooling off a bit)
The Theranos Story, ch. 73: the defense tries to stack the jury deck in Holmes’ favor, prosecutors say. And Theranos swag and memes are hot! (Voir dire antics, but is it admiration of or sarcastic fun at the “Girl Boss” “faking it till she made it”?)
OnePerspective: How the shift from analogue to digital telephone services affects telecare provisioning (A POV from Chubb for our UK Readers)

A ‘shortie’ this short week for many of us, especially this Editor. Our highlight is the breaking news our UK Readers may have missed on NHS’ controversial GPDPR implementation–and why it’s significant to everyone. Plus Babylon and Tunstall news.

Tunstall Group acquires Secuvita (NL) (Bucking up their Benelux business)
NHS Digital GPDPR medical database plans criticized by Royal College of GPs, privacy advocates (updated) (Data use and patient privacy issues here have resonance everywhere)
Babylon Health going the SPAC route with Alkuri Global: reports (Surprising it hasn’t happened earlier)

A bumper crop as we ease into the unofficial start of summer and wind up May

ATA2021 coming up (virtually) starting 1 June  (Through June–but at least you don’t have to get the jab before attending!)
News and deals roundup: CoverMyMeds ‘big bang’, Noom’s $540M Series F, insurtech Bright Health’s IPO, Grand Rounds-Included Health, GoodRx, Cedar-OODA, Huma, Bluestream Health’s outreach (So many we had to ‘short take’ them!)
UK news roundup: West Wales’ CONNECT project, WelcoMe app for disabled access, X-on Surgery Connect expands, Arc Health in 46 care homes, Alcove’s £75M contract with Suffolk County Council (Things moving along smartly)
An unappreciated long term pandemic health effect? Increased frailty among older adults. (Making up for lost time and health not easy or quick)
The Theranos Story, ch. 72: a little lifestyle and celebrity is admissible at trial–but not too much. And no profanity, please! (Hold the popcorn till Labor Day)
News and deals roundup: SCP Health-SOC Telemed, Epion Health-MSU, Sensyne Health’s new data agreements, Geisinger’s RPM app (Definitely ‘springing forward’)
Survey: 80% of Americans believe telehealth can provide quality medical care–up 23 points from 2020 (More confirmation of five years of progress in one)

From last week’s mini-update–our ‘top of the pops’ 

Tunstall excluded from Sweden’s framework agreements for municipal alarm and technology procurement (A software update that went sideways affects contracts in over 200 municipalities)

A small bombshell in the traditional PERS world (yes, it’s still there) is Philips’ sale of Lifeline to Connect America–which two years ago bought Tunstall Americas. Teladoc gets into the cognitive therapy app business–and sends a message–in a big way.

Connect America acquires Philips’ Aging and Caregiving, including Lifeline (Big news in aging services, though it’s Old Tech. And another Philips North America divestiture.)
Teladoc integrates the myStrength cognitive mental health app with their telehealth network (Sending a message to the smaller players?)

 

And of continued interest….

The Theranos Story, ch. 71: Holmes appears in court, lawyers argue celebrity, lavish lifestyle, Silicon Valley ethics (The consequences of ‘faking till you make it’)
What you need to know about Germany’s new DiGA fast tracking for health apps (New R2G research)

Breaking: NHS Digital appoints Simon Bolton interim CEO

David sues Goliath: AliveCor claims patent infringement by Apple–ITC filing requests bar on Apple Watch US importation (Bring the popcorn, but it’s serious)
News roundup: Buddi’s £500M LSE float, Accolade to buy PlushCare for $450M, Teladoc adds chief innovation officer, Tyto Care’s Italy expansion (Buddi a huge float for the UK)

Mayo Clinic creates AI-powered clinical decision/diagnostics support platform, two digital health portfolio companies (What Dr. John Halamka’s been up to)
A new event–and not all virtual! HLTH and CHIME to launch ViVE in March 2022. (Another sign of normal business)

Have a job to fill? Seeking a position? Free listings available to match our Readers with the right opportunities. Email Editor Donna.


Read Telehealth and Telecare Aware: https://telecareaware.com/  @telecareaware

Follow our pages on LinkedIn and on Facebook

We thank our present and past advertisers and supporters: Legrand/Tynetec, Eldercare, UK Telehealthcare, NYeC, PCHAlliance, ATA, The King’s Fund, DHACA, HIMSS, Health 2.0 NYC, MedStartr, Parks Associates, and HealthIMPACT.

Reach international leaders in health tech by advertising your company or event/conference in TTA–contact Donna for more information on how we help and who we reach. See our advert information here. 


Telehealth & Telecare Aware: covering the news on latest developments in telecare, telehealth, telemedicine and health tech, worldwide–thoughtfully and from the view of fellow professionals

Thanks for asking for update emails. Please tell your colleagues about this news service and, if you have relevant information to share with the rest of the world, please let me know.

Donna Cusano, Editor In Chief
donna.cusano@telecareaware.com

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

NHS Digital GPDPR medical database data extraction start postponed from 1 July to 1 September

Facing a GP revolt and legal action, NHS Digital has postponed the extraction of patient data records from surgeries until 1 September for the General Practice Data for Planning and Research (GPDPR). Before the House of Commons on 8 June, health minister Jo Churchill announced the extension. “We will use this time to talk to patients, doctors, health charities and others to strengthen the plan, build a trusted research environment and ensure data is accessed securely.” Health secretary Matt Hancock also announced that the patient opt-out deadline, originally 23 June, will be extended (date TBD). Pulse (may require registration), NHS revised release

On 4 June, before the extension announcement, the Doctors Association UK (DAUK), the Citizens, openDemocracy, the National Pensioners Convention, and Conservative MP David Davis were among the signatories to a legal letter sent to the Department of Health and Social Care (DHSC) threatening action to halt the data collection from GPs. Pulse (may require registration)   

While Ms. Churchill, Mr. Hancock, and Simon Bolton collectively insist that the additional time will be used for consultations with patients, doctors, health charities, and others, the proof will be in both the data collection and how informed patients will be of their options. Both the opt-out date and September, given the summer holidays, aren’t much time. In this Editor’s estimation, for a major effort, the end of this year would be far better. Perhaps we should send them this poster? Additional TTA coverage 2 June.

TTA’s summer startup #2: controversy around NHS’ GPDPR patient database, Babylon Health’s likely SPAC, Tunstall buys Secuvita, more!

 

 

Weekly Alert

A ‘shortie’ this short week for many of us, especially this Editor. Our highlight is the breaking news our UK Readers may have missed on NHS’ controversial GPDPR implementation–and why it’s significant to everyone. Plus Babylon and Tunstall news.

Tunstall Group acquires Secuvita (NL) (Bucking up their Benelux business)
NHS Digital GPDPR medical database plans criticized by Royal College of GPs, privacy advocates (updated) (Data use and patient privacy issues here have resonance everywhere)
Babylon Health going the SPAC route with Alkuri Global: reports (Surprising it hasn’t happened earlier)

A bumper crop as we ease into the unofficial start of summer and wind up May

ATA2021 coming up (virtually) starting 1 June (At least you don’t have to get the jab before attending!)
News and deals roundup: CoverMyMeds ‘big bang’, Noom’s $540M Series F, insurtech Bright Health’s IPO, Grand Rounds-Included Health, GoodRx, Cedar-OODA, Huma, Bluestream Health’s outreach (So many we had to ‘short take’ them!)
UK news roundup: West Wales’ CONNECT project, WelcoMe app for disabled access, X-on Surgery Connect expands, Arc Health in 46 care homes, Alcove’s £75M contract with Suffolk County Council (Things moving along smartly)
An unappreciated long term pandemic health effect? Increased frailty among older adults. (Making up for lost time and health not easy or quick)
The Theranos Story, ch. 72: a little lifestyle and celebrity is admissible at trial–but not too much. And no profanity, please! (Hold the popcorn till Labor Day)
News and deals roundup: SCP Health-SOC Telemed, Epion Health-MSU, Sensyne Health’s new data agreements, Geisinger’s RPM app (Definitely ‘springing forward’)
Survey: 80% of Americans believe telehealth can provide quality medical care–up 23 points from 2020 (More confirmation of five years of progress in one)

From last week’s mini-update–our ‘top of the pops’ 

Tunstall excluded from Sweden’s framework agreements for municipal alarm and technology procurement (A software update that went sideways affects contracts in over 200 municipalities)

A small bombshell in the traditional PERS world (yes, it’s still there) is Philips’ sale of Lifeline to Connect America–which two years ago bought Tunstall Americas. Teladoc gets into the cognitive therapy app business–and sends a message–in a big way.

Connect America acquires Philips’ Aging and Caregiving, including Lifeline (Big news in aging services, though it’s Old Tech. And another Philips North America divestiture.)
Teladoc integrates the myStrength cognitive mental health app with their telehealth network (Sending a message to the smaller players?)

 

May may be chilly where you are, but we serve up some hot news in funding, wobbly Walmart’s dive into telehealth, Germany’s DiGA, a OnePerspective around stroke care, and a free webinar on what public health may look like post-Covid. And kicking off the month–a Theranos hearing (remember them?)

The Theranos Story, ch. 71: Holmes appears in court, lawyers argue celebrity, lavish lifestyle, Silicon Valley ethics (The consequences of ‘faking till you make it’)
News and funding roundup: Vida Health’s $100M Series D, Kry’s $316M raise, CVS and Advocate Aurora’s fresh funds, Boost Mobile offers K Health symptom checker (Substantial raises and more funding on the table)
Walmart Health moves into the hot telehealth area with MeMD buy (Continuing to be a puzzle)
What you need to know about Germany’s new DiGA fast tracking for health apps (New R2G research)
Webinar: Public Health and Responsible Innovation in a Post-Covid Europe 20 May
OnePerspective: Covid-19 accelerates digital stroke care for the East of England (Stroke Telemedicine Partnership with Visionable)

And of continued interest–

Breaking: NHS Digital appoints Simon Bolton interim CEO

2021 UK-RAS Network Robotics Summer Showcase 5 May-30 July and UK Festival of Robotics 19-25 June (If you’re interested in healthcare or other robotics, this is the place–and not just for the UK)
David sues Goliath: AliveCor claims patent infringement by Apple–ITC filing requests bar on Apple Watch US importation (Bring the popcorn, but it’s serious)
Amwell debuts new telehealth platform, Converge; previews Carepoint for hospital care into the home (Carepoint is the ‘stealthy’ move)
News roundup: Buddi’s £500M LSE float, Accolade to buy PlushCare for $450M, Teladoc adds chief innovation officer, Tyto Care’s Italy expansion (Buddi a huge float for the UK)

Mayo Clinic creates AI-powered clinical decision/diagnostics support platform, two digital health portfolio companies (What Dr. John Halamka’s been up to)
A new event–and not all virtual! HLTH and CHIME to launch ViVE in March 2022. (Another sign of normal business)
Good news! Eight software functions no longer classified as medical devices under FDA. (One for the techies. And anything you don’t have to clear with FDA makes for a good day.)

Have a job to fill? Seeking a position? Free listings available to match our Readers with the right opportunities. Email Editor Donna.


Read Telehealth and Telecare Aware: https://telecareaware.com/  @telecareaware

Follow our pages on LinkedIn and on Facebook

We thank our present and past advertisers and supporters: Legrand/Tynetec, Eldercare, UK Telehealthcare, NYeC, PCHAlliance, ATA, The King’s Fund, DHACA, HIMSS, Health 2.0 NYC, MedStartr, Parks Associates, and HealthIMPACT.

Reach international leaders in health tech by advertising your company or event/conference in TTA–contact Donna for more information on how we help and who we reach. See our advert information here. 


Telehealth & Telecare Aware: covering the news on latest developments in telecare, telehealth, telemedicine and health tech, worldwide–thoughtfully and from the view of fellow professionals

Thanks for asking for update emails. Please tell your colleagues about this news service and, if you have relevant information to share with the rest of the world, please let me know.

Donna Cusano, Editor In Chief
donna.cusano@telecareaware.com

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

NHS Digital GPDPR medical database plans criticized by Royal College of GPs, privacy advocates (updated 8 June)

What our UK Readers may have missed on the long bank holiday weekend. And why this matters outside the UK.  NHS Digital is being roundly criticized by privacy advocates, the Royal College of GPs (RCGP), the Doctors’ Association UK (DAUK), and individual GP surgeries on plans for creation of the General Practice Data for Planning and Research (GPDPR).

The GPDPR will compile information on 55 million patients–every patient in England registered with a GP surgery–into a database available to academic and commercial third parties for research and planning purposes. NHS has been collecting patient data on patients in a database, the General Practice Extraction Service (GPES), for the past decade. The GPDPR will replace it. Data collection on patients in England starts 1 July. What will be collected is at the end of this article as background.

The objections center on the sensitivity of the data, the short window of notification to patients, the lack of a clearly notified opt-out with sufficient time, and how it will be used.

  • The data apparently can include mental and sexual health data, criminal records (!), and other sensitive information. 
  • The short time–six weeks–between the announcement in late April (a low key affair with Matt Hancock-signed blog posts on the NHS Digital website, YouTube videos, and flyers at GP surgeries), and the start of data collection from the surgeries
  • How many patients are actually aware that this is happening and of their options is debatable. (See next two bullets)
    • If a patient didn’t pick up on it in the six-week window ending on 23 June (and go to the page with the Type 1 Opt-Out), a patient can opt out for data going forward, but cannot withdraw any data collected into the database prior to that date.
    • If a patient is in the National Data Opt-out program, their medical data will be collected anyway, since it applies to only identifiable and confidential patient information.
  • Many GPs are concerned about further erosion of the physician-patient relationship and the lack of communication to patients on how the data will be used, the ethical questions around the organizations to which it will be sold, and how patient privacy will be preserved.

The blackest mark here on NHS Digital is that the groups ostensibly involved in the development of the database–the RCGP and the British Medical Association (BMA)–are the ones sounding the alarm, along with the aforementioned DAUK and privacy groups such as MedConfidential and Foxglove. There is also a rebellion starting among London GPs. Reportedly, 36 doctors’ surgeries in Tower Hamlets, east London, will withhold data. An email is circulating to about 100 surgeries in north London questioning the legitimacy of the NHS data collection. This is despite penalties if they don’t submit.

Why does this matter if you’re not in England? Medical data–collecting, manipulating it, connecting it, finding insights, and selling it–is the Gold Rush of the 2020s. Pharma and payers as markets are just the start. Nearly every Roundup or deal this Editor covers has companies with a chunk of this gold rush. Why are telehealth companies worth their IPO/SPAC/funding prices? Why is McKesson ‘big banging’ four separate businesses into one division? Why do we follow ‘data warehouses’ like Sensyne [TTA 26 May],  Mayo Clinic’s big bet on a multi-line Remote Diagnostics and Management Platform [TTA 23 Apr], and virtual pharmacies like Capsule?  Why are insurtechs like Oscar and Bright Health hot? Why is it the #1 target of hackers?

It’s not altruistic. Services can be duplicated. Companies can be a hair away from failure. But ah, their data…the data has huge market value, even if its potential is not fully understood yet. Ask any data analytics person. Ask China, probably the most aggressive nation in collecting the health and personal data of its citizens, with Chinese capital for years now leading investment in global health tech companies.

In an article back in October 2015, this Editor described the many ways that deidentified patient data, in this case genomic data, can be identified by researchers through cross-checking via research database “beacons”, a network of servers. Referring to the 23andme and Ancestry.com collection of innocently given genomic data from consumers, this Editor proposed a Genomic Bill of Rights in 2018 and again in 2020. If this Editor, no data geek, can deduce it (hat tip to Toni Bunting back in 2015), this information has to be well known to researchers and to privacy advocates.

The controversy is just starting to ramp up. And it should. It’s about time there was a reckoning. The Guardian 30 May, 1 June

More background. According to the NHS Digital page on the GPDPR, patients will be anonymized by a process where de-identification software will replace their NHS Number, date of birth, and full postcode with unique codes produced by de-identification software. The data collected from GPs in England starting 1 July will be on: (more…)